Mode of antagonism between beta-adrenergic drugs and prostaglandin F2-alpha.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001986:Bronchial Spasm / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000502:physiology; D010208:Papaverine; D011448:Prostaglandin Antagonists; D014132:Trachea / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D011448:Prostaglandin Antagonists; D010208:Papaverine; D007545:Isoproterenol